0001193125-26-210356
SEC filingVital Farms delivered revenue growth of 15.4% to $187.2M in Q1 FY2026, but profitability and cash flow deteriorated sharply — operating income swung to a $2.3M loss and free cash flow was -$39.3M — as the company executed supply controls and paused strategic investments amid egg oversupply and margin pressure.
Revenue for Q1 FY2026 totaled $187.2M, an increase of 15.4% compared to $162.2M in Q1 FY2025. This growth reflects volume favorability, which management attributes to accelerated demand for existing products, expanded item offerings, and broader store distribution at existing customers. Net revenue variability is acknowledged to depend on purchase orders received, the volume and mix of products sold, and the channels through which products are distributed — all factors consistent with the reported outcome. While pricing and mix headwinds were present due to industry egg oversupply, the underlying volume momentum remained intact.
Gross profit decreased 15.2% to $53.0M, and gross margin contracted to 28.3%. This compression occurred against a backdrop of external market conditions — specifically, sustained egg oversupply — which affected pricing power and product mix. Management notes that revenue may vary period to period depending on channel and mix, and that price increases to date have not materially reduced sales volumes, though further increases could dampen demand. No quantified attribution of margin pressure to specific channels or products is supported in the authoritative packet; therefore, the explanation remains grounded in disclosed operational dynamics rather than unsupported segment-level claims.
Operating income declined to -$2.3M from $21.8M year-over-year. This reversal reflects both elevated investment activity and the recognition of ERP-related costs in selling, general and administrative expenses — as explicitly stated in management commentary. Capital expenditures totaled $20.8M, more than six times the prior-year level, supporting infrastructure and systems modernization. Management confirms that future capital requirements depend on customer growth pace, innovation investments, and production capacity expansion — all active priorities during the quarter.
Net cash provided by operating activities was -$18.6M, resulting in free cash flow of -$39.3M. This outflow reflects the timing of strategic investments and working capital dynamics, not a change in underlying business model viability. Management states it is evaluating financing options and/or cost reduction measures based on expected future liquidity and anticipated cash requirements — a forward-looking statement directly sourced from Item 2. The company also reiterates uncertainty regarding agricultural disease impacts, noting that while no material disruptions have occurred to date from HPAI or EDS, substantial outbreaks could materially affect the supply chain and operating results.